PT1420780E - Análogos ciclopropilados e ciclobutilados da epotilona - Google Patents

Análogos ciclopropilados e ciclobutilados da epotilona Download PDF

Info

Publication number
PT1420780E
PT1420780E PT02767418T PT02767418T PT1420780E PT 1420780 E PT1420780 E PT 1420780E PT 02767418 T PT02767418 T PT 02767418T PT 02767418 T PT02767418 T PT 02767418T PT 1420780 E PT1420780 E PT 1420780E
Authority
PT
Portugal
Prior art keywords
cyclopropyl
cyclobutyl
epothilone analogs
compounds
cyclobutyl epothilone
Prior art date
Application number
PT02767418T
Other languages
English (en)
Inventor
Karl-Heinz Altmann
Kyriacos Costa Nicolaou
Andreas Ritzen
Kenji Namoto
Trond Ulven
Mutsuru Shoji
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT1420780E publication Critical patent/PT1420780E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
PT02767418T 2001-08-23 2002-08-22 Análogos ciclopropilados e ciclobutilados da epotilona PT1420780E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31469801P 2001-08-23 2001-08-23

Publications (1)

Publication Number Publication Date
PT1420780E true PT1420780E (pt) 2008-12-29

Family

ID=23221047

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02767418T PT1420780E (pt) 2001-08-23 2002-08-22 Análogos ciclopropilados e ciclobutilados da epotilona

Country Status (13)

Country Link
US (1) US7358266B2 (pt)
EP (2) EP2070534A3 (pt)
JP (2) JP4176015B2 (pt)
CN (1) CN100536841C (pt)
AT (1) ATE409473T1 (pt)
AU (1) AU2002331171A1 (pt)
BR (1) BR0212107A (pt)
CA (1) CA2456280A1 (pt)
DE (1) DE60229143D1 (pt)
ES (1) ES2315399T3 (pt)
HK (1) HK1066464A1 (pt)
PT (1) PT1420780E (pt)
WO (1) WO2003018002A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU756699B2 (en) 1996-12-03 2003-01-23 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6867305B2 (en) 1996-12-03 2005-03-15 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
PT1420780E (pt) * 2001-08-23 2008-12-29 Novartis Ag Análogos ciclopropilados e ciclobutilados da epotilona
ES2297189T3 (es) * 2002-08-02 2008-05-01 Novartis Ag Derivados de epotilona.
JP4791183B2 (ja) * 2002-08-23 2011-10-12 スローン−ケッタリング インスティトュート フォア キャンサー リサーチ エポチロン、その中間体、類似体の合成およびその使用
US7649006B2 (en) * 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US7384964B2 (en) * 2002-08-23 2008-06-10 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US20050171167A1 (en) 2003-11-04 2005-08-04 Haby Thomas A. Process and formulation containing epothilones and analogs thereof
GB0405898D0 (en) * 2004-03-16 2004-04-21 Novartis Ag Organic compounds
CN101535492A (zh) 2005-02-11 2009-09-16 南加州大学 表达含有二硫键的蛋白质的方法
CN101360494A (zh) * 2005-11-22 2009-02-04 斯克里普斯研究学院 高效埃博霉素的化学合成
WO2007130501A2 (en) * 2006-05-01 2007-11-15 University Of Southern California Combination therapy for treatment of cancer
JP5115729B2 (ja) * 2008-06-20 2013-01-09 信越化学工業株式会社 トリアルキルシリル基で保護されたアセト酢酸エステル基含有有機ケイ素化合物及びその製造方法
WO2010056901A2 (en) 2008-11-13 2010-05-20 University Of Southern California Method of expressing proteins with disulfide bridges with enhanced yields and activity
AU2011255647A1 (en) 2010-05-18 2012-11-15 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases
CN115850224A (zh) * 2022-07-22 2023-03-28 北京先通国际医药科技股份有限公司 一种修饰长链脂肪酸型pet试剂前体的合成方法及其用途
CN115141087B (zh) * 2022-09-06 2023-03-24 北京先通国际医药科技股份有限公司 Pet前体关键中间体的异构体的合成方法及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5969145A (en) * 1996-08-30 1999-10-19 Novartis Ag Process for the production of epothilones and intermediate products within the process
US6380394B1 (en) * 1996-12-13 2002-04-30 The Scripps Research Institute Epothilone analogs
US6441186B1 (en) * 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
US6380395B1 (en) * 1998-04-21 2002-04-30 Bristol-Myers Squibb Company 12, 13-cyclopropane epothilone derivatives
DE19848306A1 (de) * 1998-10-14 2000-04-20 Schering Ag Verfahren zur Herstellung von Epothilon B und Derivaten sowie Zwischenprodukte für dieses Verfahren
SK11452001A3 (sk) * 1999-02-11 2002-04-04 Schering Aktiengesellschaft Deriváty epotilónu, farmaceutický prípravok s ich obsahom a ich použitie
PT1420780E (pt) * 2001-08-23 2008-12-29 Novartis Ag Análogos ciclopropilados e ciclobutilados da epotilona

Also Published As

Publication number Publication date
WO2003018002A3 (en) 2003-09-04
US20040039026A1 (en) 2004-02-26
EP2070534A2 (en) 2009-06-17
US7358266B2 (en) 2008-04-15
JP2005501107A (ja) 2005-01-13
ATE409473T1 (de) 2008-10-15
CN1545411A (zh) 2004-11-10
ES2315399T3 (es) 2009-04-01
CA2456280A1 (en) 2003-03-06
HK1066464A1 (en) 2005-03-24
WO2003018002A2 (en) 2003-03-06
CN100536841C (zh) 2009-09-09
DE60229143D1 (en) 2008-11-13
EP1420780A2 (en) 2004-05-26
AU2002331171A1 (en) 2003-03-10
JP2009007367A (ja) 2009-01-15
EP2070534A3 (en) 2009-08-26
JP4176015B2 (ja) 2008-11-05
BR0212107A (pt) 2004-08-24
EP1420780B1 (en) 2008-10-01

Similar Documents

Publication Publication Date Title
HK1066464A1 (en) Cyclopropyl and cyclobutyl epothilone analogs
MXPA04000756A (es) Nuevos compuestos.
EP1256588A4 (en) NEW PYRAZINE DERIVATIVES OR SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THE DERIVATIVES OR THEIR SALTS AND INTERMEDIATES FOR BOTH PRODUCTION
IL148384A0 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
MY129422A (en) Medicinal compounds
WO2004026863A8 (en) Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors
NO20051209L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme
ZA200604719B (en) DPP-IV inhibitors
MXPA04005099A (es) Derivados de 5-sulfanil-4h-1,2,4-triazol y su uso como medicamento.
HUT54357A (en) Process for producing benzilidene-(azolylmethyl)-cycloalkane and -cycloalkene derivatives, fungicidal compositions comprising such compounds as active ingredient and intermediates usable for the production of the active ingredients
BG105137A (en) Antiparasitic artemisinin derivatives (endoperoxides)
DE60330407D1 (de) Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung
MXPA04004548A (es) Acidos heteroarilalalcanoicos substituidos y su uso como inhibidores de aldosa reductasa.
GB0114004D0 (en) Chemical compounds
IL172290A0 (en) Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain
DK0826681T3 (da) Epoxyravsyrederivater
AU4811396A (en) Substituted benzothienylpiperazines their use as medicaments, and processes for their preparation
GB9912417D0 (en) Compounds useful in therapy
WO2004074249A3 (en) Synthesis of peloruside a and analogs thereof for use as antitumor agents
WO2005056000A3 (fr) Substance neuroactive et utilisations d'une telle substance
TH68162A (th) อิมิดาโซควิโนลีนซึ่งถูกแทนที่ด้วยซัลโฟนามิโดอีเทอร์